278 related articles for article (PubMed ID: 17973322)
1. Skeletal Langerhans cell histiocytosis in children: permanent consequences and health-related quality of life in long-term survivors.
Lau LM; Stuurman K; Weitzman S
Pediatr Blood Cancer; 2008 Mar; 50(3):607-12. PubMed ID: 17973322
[TBL] [Abstract][Full Text] [Related]
2. Permanent consequences in Langerhans cell histiocytosis patients: a pilot study from the Histiocyte Society-Late Effects Study Group.
Haupt R; Nanduri V; Calevo MG; Bernstrand C; Braier JL; Broadbent V; Rey G; McClain KL; Janka-Schaub G; Egeler RM
Pediatr Blood Cancer; 2004 May; 42(5):438-44. PubMed ID: 15049016
[TBL] [Abstract][Full Text] [Related]
3. Permanent disabilities in childhood survivors of Langerhans cell histiocytosis.
Kusumakumary P; James FV
Pediatr Hematol Oncol; 2000; 17(5):375-81. PubMed ID: 10914047
[TBL] [Abstract][Full Text] [Related]
4. Long term morbidity and health related quality of life after multi-system Langerhans cell histiocytosis.
Nanduri VR; Pritchard J; Levitt G; Glaser AW
Eur J Cancer; 2006 Oct; 42(15):2563-9. PubMed ID: 16959486
[TBL] [Abstract][Full Text] [Related]
5. Central nervous system-related permanent consequences in patients with Langerhans cell histiocytosis.
Mittheisz E; Seidl R; Prayer D; Waldenmair M; Neophytou B; Pötschger U; Minkov M; Steiner M; Prosch H; Wnorowski M; Gadner H; Grois N
Pediatr Blood Cancer; 2007 Jan; 48(1):50-6. PubMed ID: 16470521
[TBL] [Abstract][Full Text] [Related]
6. High incidence of hearing loss in long-term survivors of multisystem Langerhans cell histiocytosis.
Nanduri V; Tatevossian R; Sirimanna T
Pediatr Blood Cancer; 2010 Mar; 54(3):449-53. PubMed ID: 19813249
[TBL] [Abstract][Full Text] [Related]
7. Pattern and course of single-system disease in Langerhans cell histiocytosis data from the DAL-HX 83- and 90-study.
Titgemeyer C; Grois N; Minkov M; Flucher-Wolfram B; Gatterer-Menz I; Gadner H
Med Pediatr Oncol; 2001 Aug; 37(2):108-14. PubMed ID: 11496348
[TBL] [Abstract][Full Text] [Related]
8. Craniospinal Langerhans cell histiocytosis in children: 30 years' experience at a single institution.
Davidson L; McComb JG; Bowen I; Krieger MD
J Neurosurg Pediatr; 2008 Mar; 1(3):187-95. PubMed ID: 18352762
[TBL] [Abstract][Full Text] [Related]
9. Health-related quality of life, cognitive functioning and behaviour problems in children with Langerhans cell histiocytosis.
Vrijmoet-Wiersma CM; Kooloos VM; Koopman HM; Kolk AM; van der Laan I; Grootenhuis MA; Egeler RM
Pediatr Blood Cancer; 2009 Jan; 52(1):116-22. PubMed ID: 18819122
[TBL] [Abstract][Full Text] [Related]
10. Nationwide survey of single-system single site Langerhans cell histiocytosis in Japan.
Morimoto A; Ishida Y; Suzuki N; Ohga S; Shioda Y; Okimoto Y; Kudo K; Ishii E;
Pediatr Blood Cancer; 2010 Jan; 54(1):98-102. PubMed ID: 19728332
[TBL] [Abstract][Full Text] [Related]
11. Hearing loss, quality of life, and academic problems in long-term neuroblastoma survivors: a report from the Children's Oncology Group.
Gurney JG; Tersak JM; Ness KK; Landier W; Matthay KK; Schmidt ML;
Pediatrics; 2007 Nov; 120(5):e1229-36. PubMed ID: 17974716
[TBL] [Abstract][Full Text] [Related]
12. Cognitive outcome of long-term survivors of multisystem langerhans cell histiocytosis: a single-institution, cross-sectional study.
Nanduri VR; Lillywhite L; Chapman C; Parry L; Pritchard J; Vargha-Khadem F
J Clin Oncol; 2003 Aug; 21(15):2961-7. PubMed ID: 12885816
[TBL] [Abstract][Full Text] [Related]
13. Cutaneous Langerhans cell histiocytosis in children under one year.
Lau L; Krafchik B; Trebo MM; Weitzman S
Pediatr Blood Cancer; 2006 Jan; 46(1):66-71. PubMed ID: 16261594
[TBL] [Abstract][Full Text] [Related]
14. Quality of survival in children and adolescents after treatment for childhood cancer: the influence of reported late effects on health related quality of life.
Calaminus G; Weinspach S; Teske C; Göbel U
Klin Padiatr; 2007; 219(3):152-7. PubMed ID: 17525909
[TBL] [Abstract][Full Text] [Related]
15. Pulmonary Langerhans cell histiocytosis: a variable disease in childhood.
Odame I; Li P; Lau L; Doda W; Noseworthy M; Babyn P; Weitzman S
Pediatr Blood Cancer; 2006 Dec; 47(7):889-93. PubMed ID: 16276522
[TBL] [Abstract][Full Text] [Related]
16. Reactivation and risk of sequelae in Langerhans cell histiocytosis.
Pollono D; Rey G; Latella A; Rosso D; Chantada G; Braier J
Pediatr Blood Cancer; 2007 Jun; 48(7):696-9. PubMed ID: 17252574
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for diabetes insipidus in langerhans cell histiocytosis.
Grois N; Pötschger U; Prosch H; Minkov M; Arico M; Braier J; Henter JI; Janka-Schaub G; Ladisch S; Ritter J; Steiner M; Unger E; Gadner H;
Pediatr Blood Cancer; 2006 Feb; 46(2):228-33. PubMed ID: 16047354
[TBL] [Abstract][Full Text] [Related]
18. Central diabetes insipidus as presenting symptom of Langerhans cell histiocytosis.
Prosch H; Grois N; Prayer D; Waldhauser F; Steiner M; Minkov M; Gadner H
Pediatr Blood Cancer; 2004 Oct; 43(5):594-9. PubMed ID: 15382278
[TBL] [Abstract][Full Text] [Related]
19. Endocrine involvement in pediatric-onset Langerhans' cell histiocytosis: a population-based study.
Donadieu J; Rolon MA; Thomas C; Brugieres L; Plantaz D; Emile JF; Frappaz D; David M; Brauner R; Genereau T; Debray D; Cabrol S; Barthez MA; Hoang-Xuan K; Polak M;
J Pediatr; 2004 Mar; 144(3):344-50. PubMed ID: 15001940
[TBL] [Abstract][Full Text] [Related]
20. Radiological evaluation of patients with pituitary langerhans cell histiocytosis at diagnosis and at follow-up.
Varan A; Cila A; Akyüz C; Kale G; Kutluk T; Büyükpamukçu M
Pediatr Hematol Oncol; 2008 Sep; 25(6):567-74. PubMed ID: 18728976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
